HLA-C and neoplasm: HPV– HNSCCs have a more immune-suppressed TME, with high frequencies of PD-1–expressing CD4+ Th1 cells, accumulation of tumor-associated macrophages (TAMs) and MDSCs, and high MHC expression and tumor immunogenicity of tumor antigens (56–61).